Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chugai Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥11.88T | 33.5x | 3.7 | JP¥7,339 | 2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -9% Downside | Upgrade to Pro+ | |
Daiichi Sankyo | Tokyo | Healthcare | Pharmaceuticals | JP¥9.3T | 40.5x | 0.74 | JP¥4,867 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33.9% Upside | Upgrade to Pro+ | |
Takeda Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥6.58T | 43.5x | -0.89 | JP¥4,163 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.5% Upside | Upgrade to Pro+ | |
Otsuka Holdings Ltd | Tokyo | Healthcare | Pharmaceuticals | JP¥4.45T | 35.2x | -1.41 | JP¥8,271 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8% Upside | Upgrade to Pro+ | |
Astellas Pharma Inc. | Tokyo | Healthcare | Pharmaceuticals | JP¥3.04T | 141.1x | -1.82 | JP¥1,709.50 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.3% Upside | Upgrade to Pro+ | |
Shionogi | Tokyo | Healthcare | Pharmaceuticals | JP¥1.81T | 4.1x | -0.61 | JP¥2,137.50 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.2% Upside | Upgrade to Pro+ | |
Eisai | Tokyo | Healthcare | Pharmaceuticals | JP¥1.56T | 48.5x | -1.5 | JP¥5,525 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33.2% Upside | Upgrade to Pro+ | |
Kyowa Kirin | Tokyo | Healthcare | Pharmaceuticals | JP¥1.34T | 14.1x | 0.12 | JP¥2,572.50 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.9% Upside | Upgrade to Pro+ | |
Ono Pharmaceutical Ltd | Tokyo | Healthcare | Pharmaceuticals | JP¥910.64B | 7.6x | 0.96 | JP¥1,943 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.9% Upside | Upgrade to Pro+ | |
Rohto Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥831.79B | 27.6x | 4.04 | JP¥3,669 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8% Upside | Upgrade to Pro+ | |
Santen Pharmaceutical Co Ltd | Tokyo | Healthcare | Pharmaceuticals | JP¥624.29B | 24.3x | 0.07 | JP¥1,788.50 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.5% Upside | Upgrade to Pro+ | |
Medipal Holdings Corp | Tokyo | Healthcare | Pharmaceuticals | JP¥526.33B | 13.6x | -3.11 | JP¥2,530.50 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4.2% Downside | Upgrade to Pro+ | |
Suzuken Co Ltd | Tokyo | Healthcare | Pharmaceuticals | JP¥393.95B | 13.3x | 0.23 | JP¥5,084 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -1.1% Downside | Upgrade to Pro+ | |
Tsumura & Co | Tokyo | Healthcare | Pharmaceuticals | JP¥338.56B | 14.3x | 0.19 | JP¥4,471 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.2% Upside | Upgrade to Pro+ | |
Toho Holdings | Tokyo | Healthcare | Pharmaceuticals | JP¥291.42B | 14.1x | 0.21 | JP¥4,650 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -18% Downside | Upgrade to Pro+ | |
Hisamitsu Pharmaceutical Inc | Tokyo | Healthcare | Pharmaceuticals | JP¥290.66B | 20.6x | 2.64 | JP¥3,960 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.5% Upside | Upgrade to Pro+ | |
Sawai Group Holdings Co | Tokyo | Healthcare | Pharmaceuticals | JP¥259.51B | 3.6x | 0.21 | JP¥2,078.50 | -2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.1% Upside | Upgrade to Pro+ | |
Nippon Shinyaku | Tokyo | Healthcare | Pharmaceuticals | JP¥256.14B | 9.4x | 0.48 | JP¥3,815 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -11.7% Downside | Upgrade to Pro+ | |
Sumitomo Dainippon Pharma | Tokyo | Healthcare | Pharmaceuticals | JP¥240.36B | -0.9x | 0.01 | JP¥609 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -21.4% Downside | Upgrade to Pro+ | |
Kissei Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥158.25B | 13.4x | 8.32 | JP¥3,570 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.5% Upside | Upgrade to Pro+ | |
Kaken Pharmaceutical Co Ltd | Tokyo | Healthcare | Pharmaceuticals | JP¥151.74B | 20.1x | 0.48 | JP¥3,849 | -3.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -10.2% Downside | Upgrade to Pro+ | |
Towa Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥150.61B | 8.9x | 0.04 | JP¥3,065 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20% Upside | Upgrade to Pro+ | |
Mochida Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥121.78B | 27.8x | -2.25 | JP¥3,430 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -9.3% Downside | Upgrade to Pro+ | |
Nxera Pharma | Tokyo | Healthcare | Pharmaceuticals | JP¥115.97B | -11.4x | 0.02 | JP¥1,297 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 49.1% Upside | Upgrade to Pro+ | |
Torii Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥109.34B | 20.9x | 0.31 | JP¥3,900 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.1% Upside | Upgrade to Pro+ | |
Zeria Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥99.53B | 11.1x | 0.28 | JP¥2,256 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 40.1% Upside | Upgrade to Pro+ | |
Kyorin Holdings Inc | Tokyo | Healthcare | Pharmaceuticals | JP¥88.18B | 16x | 0.51 | JP¥1,532 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -16.8% Downside | Upgrade to Pro+ | |
JCR Pharmaceuticals | Tokyo | Healthcare | Pharmaceuticals | JP¥84.76B | 20.7x | 10.35 | JP¥680 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -11.8% Downside | Upgrade to Pro+ | |
Katakura Industries | Tokyo | Healthcare | Pharmaceuticals | JP¥67.57B | 23.9x | -2.82 | JP¥2,085 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ASKA Pharmaceutical Holdings Co | Tokyo | Healthcare | Pharmaceuticals | JP¥64.22B | 8.7x | 0.12 | JP¥2,255 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.8% Upside | Upgrade to Pro+ |